Through these two genome-wide screens and integration with CRISPR knockout datasets from T cells, MED12, CCNC, and ARIH2 were identified as candidate genes whose knockout enhances the anti-tumor response of NK cells. The gene discussed is MED12; the disease is neoplasm.